Omega Net Debt To E B I T D A from 2010 to 2024

OHI Stock  USD 40.09  0.02  0.05%   
Omega Healthcare's Net Debt To EBITDA is increasing with stable movements from year to year. Net Debt To EBITDA is predicted to flatten to 2.93. Net Debt To EBITDA is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). View All Fundamentals
 
Net Debt To EBITDA  
First Reported
2010-12-31
Previous Quarter
5.70332394
Current Value
2.93
Quarterly Volatility
1.24961566
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Omega Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omega Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 335.7 M, Interest Expense of 247.3 M or Selling General Administrative of 85.6 M, as well as many indicators such as Price To Sales Ratio of 5.5, Dividend Yield of 0.1 or PTB Ratio of 1.26. Omega financial statements analysis is a perfect complement when working with Omega Healthcare Valuation or Volatility modules.
  
Check out the analysis of Omega Healthcare Correlation against competitors.

Latest Omega Healthcare's Net Debt To E B I T D A Growth Pattern

Below is the plot of the Net Debt To E B I T D A of Omega Healthcare Investors over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). Omega Healthcare's Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omega Healthcare's overall financial position and show how it may be relating to other accounts over time.
Net Debt To E B I T D A10 Years Trend
Pretty Stable
   Net Debt To E B I T D A   
       Timeline  

Omega Net Debt To E B I T D A Regression Statistics

Arithmetic Mean5.28
Geometric Mean5.09
Coefficient Of Variation23.65
Mean Deviation0.83
Median5.56
Standard Deviation1.25
Sample Variance1.56
Range4.7152
R-Value0.20
Mean Square Error1.62
R-Squared0.04
Significance0.48
Slope0.06
Total Sum of Squares21.86

Omega Net Debt To E B I T D A History

2024 2.93
2023 5.7
2022 6.9
2021 5.77
2020 6.4
2019 5.97
2018 5.58

About Omega Healthcare Financial Statements

Investors use fundamental indicators, such as Omega Healthcare's Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Although Omega Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Net Debt To EBITDA 5.70  2.93 

Currently Active Assets on Macroaxis

When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:
Check out the analysis of Omega Healthcare Correlation against competitors.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.137
Dividend Share
2.68
Earnings Share
1.36
Revenue Per Share
4.03
Quarterly Revenue Growth
0.14
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.